Hélio Rubens Machado Selected Research

Kaolin

1/2022	Hyperbaric Oxygen Therapy Associated with Ventricular-Subcutaneous Shunt Promotes Neuroprotection in Young Hydrocephalic Rats.
1/2022	The association of Edaravone with shunt surgery improves behavioral performance, reduces astrocyte reaction and apoptosis, and promotes neuroprotection in young hydrocephalic rats.
1/2019	Behavioral and Biochemical Features of the Course and Surgical Treatment of Experimental Obstructive Hydrocephalus in Young Rats.
1/2018	Hyperbaric oxygen therapy reduces astrogliosis and helps to recovery brain damage in hydrocephalic young rats.
3/2017	Edaravone reduces astrogliosis and apoptosis in young rats with kaolin-induced hydrocephalus.
8/2016	Ventricular-subcutaneous shunt for the treatment of experimental hydrocephalus in young rats: technical note.
11/2012	0.1T magnetic resonance image in the study of experimental hydrocephalus in rats. Accuracy of the method in the measurements of the ventricular size.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hélio Rubens Machado Research Topics

Disease

11	Neoplasms (Cancer) 09/2020 - 02/2003
7	Hydrocephalus (Hydrocephaly) 01/2022 - 11/2012
4	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 02/2003
3	Gliosis 01/2022 - 03/2017
3	Glioblastoma (Glioblastoma Multiforme) 09/2020 - 01/2009
2	Carcinogenesis 01/2019 - 01/2009
2	Medulloblastoma 04/2017 - 01/2009
2	Brain Neoplasms (Brain Tumor) 02/2011 - 01/2009
1	Ischemia 01/2022
1	Neuralgia (Stump Neuralgia) 01/2021
1	Hyperalgesia 01/2021
1	Hippocampal Sclerosis 01/2020
1	Epilepsy (Aura) 01/2020
1	Hemorrhage 11/2019
1	Craniopharyngioma (Craniopharyngiomas) 07/2018
1	Disease Progression 07/2018
1	Brain Injuries (Brain Injury) 06/2018
1	Diabetes Insipidus 01/2018
1	Infratentorial Neoplasms (Posterior Fossa Tumors) 02/2011
1	Choroid Plexus Papilloma 12/2009
1	Meningioma (Meningiomas) 10/2009
1	Hypogonadism (Hypergonadotropic Hypogonadism) 02/2009
1	Hypothyroidism 02/2009
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2009
1	Pituitary ACTH Hypersecretion 01/2009
1	Cysts 01/2007
1	Glioma (Gliomas) 02/2003
1	Cognitive Dysfunction 02/2003

Drug/Important Bio-Agent (IBA)

7	KaolinIBA 01/2022 - 11/2012
4	MicroRNAs (MicroRNA)IBA 09/2020 - 01/2009
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2009
3	Neuroprotective AgentsIBA 01/2022 - 03/2017
3	Messenger RNA (mRNA)IBA 07/2018 - 01/2009
2	EdaravoneIBA 01/2022 - 03/2017
1	AntioxidantsIBA 01/2022
1	Biological ProductsIBA 09/2020
1	drebrinsIBA 01/2020
1	CaspasesIBA 11/2019
1	CannabidiolIBA 11/2019
1	InterleukinsIBA 01/2019
1	CateninsIBA 07/2018
1	Dihydrotachysterol (AT 10)IBA 06/2018
1	Free Radical ScavengersIBA 03/2017
1	Temozolomide (Temodar)FDA LinkGeneric 12/2013
1	Radiation-Sensitizing AgentsIBA 12/2013
1	Decitabine FDA Link 04/2011
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2011
1	Carrier Proteins (Binding Protein)IBA 02/2011
1	Polysaccharides (Glycans)IBA 02/2011
1	Galectin 3 (LGALS3)IBA 02/2011
1	Proteins (Proteins, Gene)FDA Link 02/2011
1	Complement System Proteins (Complement)IBA 12/2009
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 12/2009
1	ProlactinIBA 02/2009
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2009
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2009
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2007

Therapy/Procedure

3	Therapeutics 09/2020 - 04/2011
2	Aftercare (After-Treatment) 01/2019 - 01/2009
2	Ventriculoperitoneal Shunt 10/2009 - 01/2007
2	Radiotherapy 10/2009 - 02/2003
2	Drug Therapy (Chemotherapy) 01/2009 - 02/2003
1	Ligation 01/2021
1	Hemispherectomy 01/2020
1	Operative Surgical Procedures 01/2018
1	Hyperbaric Oxygenation 01/2018
1	Ventriculostomy 12/2008
1	Neoadjuvant Therapy 02/2003